Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel

Viardot A, Wais V, Sala E, Koerper S

Cancer Management and Research 2019, 11:2393-2404

Published Date: 25 March 2019